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ABSTRACT  
Background and Aims: Self-efficacy beliefs and outcome expectancies are central to Social 
Cognitive Theory (SCT). Alcohol studies demonstrate the theoretical and clinical utility of 
applying both SCT constructs. This study examined the relationship between refusal self-
efficacy and outcome expectancies in a sample of cannabis users, and tested formal 
mediational models.  
Design: Patients referred for cannabis treatment completed a comprehensive clinical 
assessment, including recently validated cannabis expectancy and refusal self-efficacy scales. 
Setting: A hospital alcohol and drug outpatient clinic. 
Participants: Patients referred for a cannabis treatment (N = 1115, mean age 26.29, SD 
9.39). 
Measurements: The Cannabis Expectancy Questionnaire (CEQ) and Cannabis Refusal Self-
Efficacy Questionnaire (CRSEQ) were completed, along with measures of cannabis severity 
(Severity of Dependence Scale [SDS]) and cannabis consumption.  
Findings: Positive (β = -.29, p < .001) and negative (β = -.19, p < .001) cannabis outcome 
expectancies were significantly associated with refusal self-efficacy. Refusal self-efficacy, in 
turn, fully mediated the association between negative expectancy and weekly consumption 
(CI95% = 0.03, 0.17) and partially mediated the effect of positive expectancy on weekly 
consumption (CI95% = 0.06, 0.17).  
Conclusions: Consistent with Social Cognitive Theory, refusal self-efficacy (a person’s 
belief that he or she can abstain from cannabis use) mediates part of the association between 
cannabis outcome expectancies (perceived consequences of cannabis use) and cannabis use.  
Key Words:  Cannabis; Expectancy; Self-Efficacy; Mediation; Dependence; Social Cognitive 
Theory
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INTRODUCTION 
Worldwide, cannabis remains the most widely used illicit substance. Twelve-month 
population estimates report between 2.8 – 4·5% of the adult global population are cannabis 
users [1]. Prevalence is generally higher in developed countries, with 9.3 – 14.8% estimates 
reported in Australasia [1]. Applying Diagnostic and Statistical Manual of Mental Disorders 
(Fifth Edition) criteria, lifetime Australian prevalence of cannabis use disorders is 5.4% [2]. 
The associated impact on morbidity – particularly mental health problems, is well 
documented [3]. Approximately half of the estimated risk of problematic cannabis use is 
genetic in origin [4,5], leaving substantial contributions from other factors.  
The contribution of environmental and cognitive mechanisms to cannabis misuse is 
not well understood. Social Cognitive Theory (SCT) [6,7] remains one of the most widely 
supported cognitive theories of the acquisition and maintenance of human behaviour. In SCT, 
Bandura identifies two constructs: self-efficacy and outcome expectancies. Outcome 
expectancies, sometimes referred to as “if... then” statements, are the perceived behavioural 
and affective consequences of engaging in specific behaviours. Self-efficacy refers to a 
person’s belief they can successfully or unsuccessfully regulate their behaviour. Bandura [8] 
promotes self-efficacy beliefs as the “foundation of human agency” (p. 3). Both belief 
systems have been applied in substance use disorder prevention and treatment research, albeit 
with a strong focus on alcohol [9,10,11]. More recently, cognitive mechanisms of cannabis 
outcome expectancy and cannabis refusal self-efficacy have been examined.  
A number of cannabis outcome expectancy measures have been developed and 
validated in non-clinical samples (Marijuana Effect Expectancy Questionnaire [12], 
Marijuana Expectancy Inventory for Children and Adolescents [13], Memory Model-Based 
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Marijuana Expectancy Questionnaire [14], Adolescent Cannabis Expectancies Questionnaire 
[15]). The Marijuana Effect Expectancy Questionnaire has also been validated though 
confirmatory factor analysis in a polysubstance treatment setting [16]. Factor structures 
typically highlight positive (e.g. “I have more self-confidence when smoking cannabis”) and 
negative (e.g. “Smoking cannabis makes me confused”) features of cannabis outcome 
expectancies. Studies consistently show that positive cannabis outcome expectancies are 
associated with cannabis use and consumption, whereas negative cannabis outcome 
expectancies are associated with non-use or reduced consumption.  
The Cannabis Expectancy Questionnaire (CEQ) [17] has been validated in cannabis 
users in treatment [18]. The two factors observed in the previous non-clinical studies - 
negative outcome expectancy and positive outcome expectancy - were also evident in the 
development of the CEQ’s clinical sample [18]. Positive cannabis expectancies were 
associated with higher weekly cannabis use, and negative expectancy with higher dependence 
severity. High positive and high negative outcome expectancies interacted to predict poorer 
health functioning, as measured by the General Health Questionnaire (GHQ-28).  
Cannabis refusal self-efficacy beliefs represent the second component of SCT. As 
with cannabis expectancies, they are associated with consumption and treatment outcomes 
[19]. Stephens et al. [20] reported that Self-Efficacy for Avoiding Marijuana Use scores [21] 
at the end of treatment added novel variance above consumption, temptation, coping, stress 
and peer use, to predict cannabis consumption up to 12 months post treatment. In a 
psychologically-based, multi-arm cannabis treatment study, patients’ refusal self-efficacy 
beliefs [20,21] were reported by Litt et al. [22] as the primary mechanism predicting 
abstinence 12 months post treatment, regardless of the psychological treatment approach 
employed. Litt et al. [23] additionally identified that self-efficacy changes over the course of 
treatment were related to coping skill development, and that both skill acquisition and refusal 
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self-efficacy contributed to reduced cannabis use. The authors concluded that treatment 
effects are directly related to the capacity of the intervention to reliably increase patient self-
refusal efficacy. Adapting the Smoking Situational Confidence Questionnaire, Burleson and 
Kaminer [24] reported that higher situational self-efficacy beliefs predicted cannabis 
abstinence during treatment. Similar to Litt et al. [21], self-efficacy improved prediction of 
abstinence independent of treatment approach.  
Despite these promising findings, the measurement of cannabis refusal self-efficacy 
did not meet minimum psychometric requirements. The Cannabis Refusal Self-Efficacy 
Questionnaire (CRSEQ) [25] has recently been validated in a cannabis treatment population 
[26]. It employed both exploratory and confirmatory construct validity, concurrent validity 
and gender invariance and reliability testing. This multi-dimensional instrument measures 
three components of cannabis refusal self-efficacy: Emotional Relief, Opportunistic and 
Social Facilitation. The sub-scales uniquely predict cannabis use and cannabis dependence 
severity and are similar in structure to the self-efficacy beliefs identified in alcohol refusal 
[27].  
To date, cannabis outcome expectancy and cannabis refusal self-efficacy have only 
been examined independently. This approach does not take full advantage of SCT. While 
findings from alcohol studies repeatedly demonstrate the predictive power of self-efficacy 
[e.g. 28, 29, 30], including both SCT constructs gives additional theoretical and clinical 
utility [9,31]. Cross-sectional studies show drinking refusal self-efficacy adds unique 
variance over alcohol outcome expectancies in predicting alcohol consumption and problem 
drinking [32,33,34,35]. Longitudinally, both alcohol outcome expectancies and drinking 
refusal self-efficacy predict alcohol consumption over a one month [36] and binge drinking 
three months later [37]. Young et al. [38] found that both alcohol expectancy and self-
efficacy beliefs could discriminate between patients who successfully completed alcohol 
 6 
 
dependence treatment from those who did not. Where formal mediation has been tested, both 
cross-sectional [39] and prospective [40] evidence suggests a significant proportion of the 
risk conveyed by alcohol expectancies for problem drinking, is mediated by self-efficacy.  
Treatment studies have identified refusal self-efficacy (as measured by the Drinking 
Refusal Self-Efficacy Questionnaire, DRSEQ [27, 41]) as the only significant mediator of 
treatment outcomes when readiness to change, perceived risk, norm estimates and positive 
drinking expectancies were also considered [42]. However, Kadden and Litt’s [19] review on 
substance abuse self-efficacy concludes that the increased recent interest in the role of refusal 
self-efficacy as a mediator of substance abuse problems would benefit from further empirical 
support. A mediating role for refusal self-efficacy makes theoretical and clinical sense. 
Almost two decades ago, Oei and Baldwin [43] noted that when an individual is presented 
with a decision, the outcome will also be dependent upon the strength of the individual’s 
belief that they are able to resist or refuse alcohol. Specifically, refusal self-efficacy beliefs 
intervene between expected outcomes and the behavioural response, in that a person who 
believes a drug to be more reinforcing will have lower confidence in their ability to resist 
using it [39, 43]. This lowered confidence is not solely the result of the heightened reward 
value of the drug, but also past experience of failures in refusal [43]. 
SCT has had considerable impact on our understanding of human behaviour, and 
along with other cognitive models, has profoundly influenced our understanding of the use 
and maintenance of substance use disorders [44,45]. Evidence suggests that concurrent use of 
both expectancy and refusal self-efficacy beliefs provide more powerful prediction of use and 
treatment outcome than independent use of these constructs. More recent research points to a 
mediational process, with evidence of refusal self-efficacy mediating outcome expectancies 
in other drug classes. Psychometrically robust cannabis outcome expectancy and cannabis 
refusal self-efficacy measures are now available to test these hypotheses [18, 26].  
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The primary aim of this study is to examine the unexplored relationship between 
outcome expectancies and refusal self efficacy, cannabis use and cannabis dependence 
severity in a cannabis using population. The secondary aim is to assess if a SCT mediational 
model is supported. The findings are expected to inform our understanding of the cognitive 
etiological of cannabis use disorders, as well as assessment, treatment and prevention 
approaches.  
 
METHOD 
Participants 
Data were obtained from 1115 cannabis users referred for treatment as part of an 
illicit drug diversion initiative. All patients attended voluntarily under court direction as an 
alternative to a criminal prosecution. The diversion program consists of a 2-hour 
comprehensive assessment of substance use and psychosocial functioning incorporating 
motivational interviewing. Referral to further treatment is provided, if indicated. Data 
collection from the program has been ongoing since 2001 and previous psychometric 
measurement studies have analysed subsamples of this dataset [18,26]. The present dataset 
contains 382 previously unanalyzed cases. Importantly, all cases included in Young et al.’s 
[26] path analysis examining cannabis refusal self-efficacy were excluded to avoid 
‘overfitting’ the hypothesized model. Therefore, none of the 1115 cases have previously been 
submitted to path analysis. Descriptive data for the sample is presented in Table 1. Human 
ethics approval was obtained. 
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______________________ 
Insert Table 1 about here 
______________________ 
Measures 
Cannabis Expectancy Questionnaire (CEQ) [17, 18]. The CEQ is a 45-item 
questionnaire assessing positive (18 items, e.g., “I get better ideas when smoking cannabis”) 
and negative (27 items, e.g., “I am more worried about what others are saying about me when 
I am smoking cannabis”) cannabis use outcome expectancies. Items included a five-point, 
Likert-style response format (1 = Strongly Disagree to 5 = Strongly Agree). The 
questionnaire was initially developed with a community sample and validated on a large 
sample of cannabis users recruited from an outpatient clinic. The two subscales have 
excellent internal consistency (α ≥ .90), and the CEQ’s factor structure and criterion validity 
have been established across two samples [18]. 
Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) [25, 26]. The CRSEQ is a 14-
item questionnaire assessing an individual’s belief in their ability to resist smoking cannabis 
across various situations. Items ask respondents to rate their ability to resist smoking cannabis 
on a 6-point Likert-type scale ranging from 1 (I am very sure I could NOT resist smoking 
cannabis) to 6 (I am very sure I could resist smoking cannabis). Similar to the Drinking 
Refusal Self-Efficacy Questionnaire [27], it comprises three subscales: Emotional Relief Self-
Efficacy (6 items; e.g., “When I feel upset”), Opportunistic Self-Efficacy (5 items; e.g., 
“When someone offers me a smoke”), and Social Facilitation Self-Efficacy (3 items; e.g., 
“When I want to feel more confident”). Like the CEQ, the questionnaire was developed with 
a community sample and validated on a large sample of cannabis users recruited from an 
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outpatient treatment service. The CRSEQ has good-to-excellent internal consistency (α = .84 
to .97), and its factor structure and criterion validity has been previously established [26]. 
Severity of Dependence Scale- Cannabis (SDS-C) [46,47]. The SDS is a 5-item 
questionnaire that is sensitive to severity of cannabis dependence [46]. Using Australian 
normative data, the SDS-C cut-off for likely cannabis dependence is ≥ 3 [47]. 
Cannabis Use was assessed by Masters- and PhD-qualified clinical psychologists 
using a retrospective diary approach over the past week. Psychologists had between 2 and 25 
years alcohol and drug treatment experience (M = 10.5 years). If cannabis was not consumed 
in the past week, an estimate of typical weekly consumption was recorded. For the purposes 
of this study, ‘joints’ (cannabis cigarette) were quantified as 0.25 grams of cannabis, and 
‘cones’ (use of ‘bong’ or ‘pipe’), 0.10 grams of cannabis. 
Data analysis 
Structural equation modelling (SEM) was conducted in R (version 2.15.2) using the 
lavaan package (version 0.5-10) [48]. The hypothesized mediation model was tested using 
maximum likelihood estimation. The three subcomponents of cannabis refusal self-efficacy 
were operationalized as latent factors, with their items serving as indicators, all loading onto a 
higher-order refusal self-efficacy latent factor [26]. Due to the large number of items on the 
CEQ, and the focus on structural relations between variables, positive and negative cannabis 
expectancy were operationalized as latent factors with parcels of items serving as indicators. 
Item parcels were created by assigning individual CEQ items to parcels on an alternating 
basis (e.g., item 1 to parcel 1, item 2 to parcel 2, item 3 to parcel 3, and so on) [as per 39,49]. 
Although both the CEQ and CRSEQ have previously demonstrated good construct validity 
[18, 26], confirmatory factor analyses (measurement models) were initially conducted on 
these scales prior to testing the structural model.  
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The comparative fit index (CFI), root mean-square error of approximation (RMSEA), 
and standardized root mean-square residual (SRMR) were used to evaluate fit [50]. The 
following criteria were employed to evaluate model fit. For “good” fit: CFI ≥ .95, RMSEA ≤ 
.06, SRMR ≤ .08 [51]. ]. Results of χ2 tests are also presented (α = .050), although they 
typically overestimate poor fit in large samples [50,51]. =Mediation was tested in two ways. 
First, the hypothesized full mediation model was compared to alternative partial mediation 
models using the chi-square difference test (Δχ2) [52]. Second, the mediation effect itself was 
estimated with the RMediation package [53] using the distribution-of-the-product method, 
which is the optimal approach to test mediation [54]. 
 
RESULTS 
There were data missing on CRSEQ items (range = 14.3% to 25.8%) and all CEQ 
item parcels (range = 13.1% to 25.7%). Additionally, 185 (16.6%) participants had missing 
data on weekly cannabis consumption, and 79 (7.1%) had missing SDS scores. Little’s 
Missing Completely at Random (MCAR) test revealed that the data were not MCAR, χ2 
(3211) = 4177.60, p < .001. Further analyses sought to determine whether data were Missing 
At Random (MAR) or Missing Not At Random (MNAR). Closer inspection revealed that 
missingness on weekly cannabis consumption were predicted by CRSEQ Item 1 (“When I am 
at a party”, p < .001) and CRSEQ Item 2 (“When someone offers me a smoke”, p < .001). 
Missingness on SDS Total was predicted by age, with older participants being less likely to 
provide SDS data (p < .001). Therefore, data were assumed to be MAR [55]. Missing data 
were imputed using Full Information Maximum Likelihood (FIML) estimation, an optimal 
strategy for handling missing data [55]. Age and sex were included in the model as auxiliary 
variables. 
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The CEQ measurement model was found to provide similar fit to that reported by 
Connor et al. [18] χ2 (26) = 149.53, p < .001, CFI = .98, RMSEA = .07 (CI90 = .06, .08), 
SRMR = .04. The CRSEQ measurement model was found to provide similar fit to that 
reported by Young et al. [26], χ2 (74) = 825.35, p < .001, CFI = .94, RMSEA = .10 (CI90 = 
.09, .11), SRMR = .04. The hypothesized full mediation model provided a good fit to the data 
(Table 2, Model 1). This model was compared to an alternative partial mediation model for 
weekly cannabis use that included additional direct paths from positive and negative 
expectancy to weekly cannabis use. This model provided a superior fit to the full mediation 
model (Table 2, Model 2). An additional model was tested, which specified extra paths from 
positive and negative expectancy to dependence severity. This model provided the best fit to 
the data and accounted for 7% and 20% of the variance in weekly consumption and 
dependence severity, respectively (Table 2, Model 3). 
As shown in Figure 1, positive (unstandardized coefficient = -0.12, SE = 0.02, p < 
.001) and negative (unstandardized coefficient = -0.06, SE = 0.01, p < .001) cannabis 
outcome expectancies were significantly associated with refusal self-efficacy. Refusal self-
efficacy, in turn, predicted weekly cannabis use (unstandardized coefficient = -0.94, SE = 
0.18, p < .001) and severity of dependence (unstandardized coefficient = -0.55, SE = 0.09, p < 
.001). Self-efficacy fully mediated the association between negative expectancy and weekly 
consumption (unstandardized mediation effect, CI95% = 0.03, 0.17). However, refusal self-
efficacy only partially mediated the effect of positive expectancy on weekly consumption 
(unstandardized mediation effect, CI95% = 0.06, 0.17). Positive outcome expectancies 
retained a significant direct association with consumption (unstandardized coefficient = 0.26, 
SE = 0.08, p < .001).  
Cannabis refusal self-efficacy fully mediated the association between positive 
outcome expectancies and severity of dependence (unstandardized mediation effect, CI95% = 
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0.04, 0.10). However, refusal self-efficacy only partially mediated the effect of negative 
outcome expectancies on dependence severity (unstandardized mediation effect, CI95% = 
0.02, 0.06). Negative outcome expectancies still had a significant direct association with 
severity of dependence (unstandardized coefficient = 0.21, SE = 0.03, p < .001). A summary 
of partial and full meditational relationships with cannabis outcome expectancies and 
cannabis refusal self-efficacy is presented in Table 3. 
______________________ 
Insert Table 2 about here 
______________________ 
______________________ 
Insert Figure 1 about here 
______________________ 
______________________ 
Insert Table 3 about here 
______________________ 
 
 
DISCUSSION 
Cannabis outcome expectancies and cannabis refusal self-efficacy beliefs have been 
independently associated with problematic use and treatment outcome. Applying Social 
Cognitive Theory (SCT) [6,7], this is the first study to examine the possible mediational 
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relationship between expectancy and self-efficacy beliefs. We applied newly developed, 
robust psychometric tools to a large clinical sample of cannabis users in treatment (N = 
1115). Findings provide partial support for a mediational relationship between cannabis 
outcome expectancies and cannabis refusal self-efficacy. 
We confirm previous reports [14,18] that positive cannabis outcome expectancies, but 
not negative outcome expectancies, were a direct and significant predictor of cannabis 
consumption. Full mediation was observed when refusal self-efficacy beliefs and negative 
expectations were combined in the one model, identifying a previously unreported pathway 
to cannabis consumption. Consistent with the SCT hypothesis, cannabis refusal self-efficacy 
played a mediating role predicting cannabis dependence severity. Full mediation was 
observed for positive outcome expectancy, partial mediation for negative outcome 
expectancy.  
Findings demonstrate two differential pathways to dependence severity and 
consumption. Consistent with Bandura’s [9] bidirectional model of substance use, it is likely 
that learned negative outcome expectancies (e.g. “I am more worried about what others are 
saying about me when I am smoking cannabis”; “I am more depressed when smoking 
cannabis”) influence dependence severity though additional biological, affective and 
environmental mechanisms. This more complex interactional model was not measured in the 
current study, potentially inflating the direct role of negative expectancy. Inclusion of these 
additional mechanisms should be an important focus of future research. For patients with 
high negative outcome expectancies, cannabis use may be driven more by perceived benefits 
of withdraw relief, and less so by positive expected outcomes. Conversely, high positive 
outcome expectancies (e.g. “I get better ideas when smoking cannabis”, “Little things annoy 
me less when I am smoking cannabis”) were not directly associated with features of cannabis 
use severity, but directly associated with consumption. The perceived lack of self-regulatory 
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skills impacts on each stage of substance use progression and treatment [9]. In the model 
tested, further support is provided for Bandura’s [8,9] position that self-efficacy is a final 
pathway to human behaviour. Perceived lack of cannabis refusal skills when faced with 
emotional, social or opportunistic challenges played a key role in mediating both negative 
and positive outcomes expectancies. This construct was the final pathway to both severity of 
dependence and level of consumption.  
The current findings indicate that modification of high negative and positive outcome 
expectancies may be equally important targets in psychological interventions aimed at 
reducing consumption. Consistent with Bandura [8,9], low refusal self-efficacy beliefs could 
be a key, end-stage pathway to heavier cannabis consumption. These are likely to provide 
additional efficacy as targets in cannabis prevention and treatment. In alcohol dependence, 
treatments aimed at developing alcohol refusal skills are effective, with therapeutic effects 
being mediated by increased self-efficacy [56]. By contrast, direct alcohol expectancy 
challenges have shown only modest efficacy, at least in prevention studies [57]. Given the 
strong association between outcome expectancies and refusal self-efficacy found for both 
alcohol and cannabis, future research needs to investigate if added benefit occurs by 
combining these two approaches.  
The study has limitations. While the sample size for this clinical sample is large and 
measurement robust, the cross-sectional design does not allow an assessment of causality. In 
analogous research, prospective alcohol studies suggest that alcohol outcome expectancies 
develop early, even vicariously [58], and play a significant role in predicting future alcohol 
problems [40]. Low refusal self-efficacy beliefs are associated with post-treatment abstinence 
[59,60]. We cannot determine from these data if similar trajectories are evident for cannabis, 
as for alcohol. The findings may not be generalizable to all cannabis users referred for 
treatment and in particular we also had a high proportion of males. Biological markers of 
 15 
 
cannabis use over a longer period would have strengthened confidence in self-report 
consumption data. Greater power from expectancies and self-efficacy in predicting cannabis 
use over specific periods may be obtained if the assessment focuses more closely on that 
period, which may not be the same as those before or afterwards. SCT emphasises the 
contextual grounding of both self-efficacy (the specific task difficulty, physiological and 
emotional state, and amount of effort that the person expects to expend) and outcome 
expectancies. The expected outcomes of further cannabis use prior to finalisation of the 
clinical and forensic issues in the current sample may be different from the expected 
outcomes in the past or future.  
Consistent with previous theoretical and empirical alcohol studies, both cannabis 
outcome expectancy and cannabis refusal self-efficacy were significant predictors of cannabis 
problems. When mediation was formally examined, partial support was observed for refusal 
self-efficacy mediating expectancy beliefs. Preliminary evidence suggests both constructs are 
important in the aetiology of cannabis use disorders.  
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Table 1.  
Descriptive Statistics (N = 1115) 
 N M SD 
Age 1106 26.29 9.39 
Weekly Consumption (grams) 930 3.59 5.85 
Past-month Alcohol Use (grams) 968 84.52 121.61 
Cigarette Use (per day; current smokers 
only, n = 583) 315 13.92 9.39 
Cannabis Expectancy Questionnaire    
Positive Expectancy 838 49.63 11.79 
Negative Expectancy 772 62.12 17.51 
Cannabis Refusal Self-Efficacy    
Emotional Relief 864 23.58 10.18 
Opportunistic 786 17.81 7.56 
Social Facilitation 833 14.35 4.02 
    
 N n  % 
Gender 1115   
Male  878 78.7 
Female  237 21.3 
Country of Origin 1115   
Australia  895 80.3 
New Zealand  74 6.6 
Other  146 13.1 
Cannabis Dependent (SDS-C ≥ 3) 1036   
Yes  493 47.6 
No  543 52.4 
Current Tobacco Smoker? 1106   
Yes  583 52.7 
No  523 47.3 
Cannabis Dependent (SDS-C ≥ 3)   
Dependent  76 57.58 
Not dependent 56 42.42 
Note. SDS-C = Severity of Dependence Scale – Cannabis. 
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Table 2 
Fit Indices for Full and Partial Mediation Models of Cannabis Cognitions and Use (N = 
1115) 
Model χ2 (df) CFI RMSEA 
(CI90%) 
SRMR Δχ2 (df) 
      
1. Full mediation model 1608.28* (314) .94 .06 (.058 - 
.064) 
.05  
2. Partial mediation model 
(Weekly cannabis use) 
1595.35* (312) .94 .06 (.058 - 
.064) 
.05 12.93# (2) 
3. Partial mediation model 
(Weekly use & 
dependence) 
1540.19* (310) .94 .06 (.057 - 
.063) 
.05 55.17* (2) 
Note. CFI = Comparative Fit Index; RMSEA = Root Mean-Square Error of Approximation; SRMR = 
Standardized Root Mean-Square Residual. 
#p = .002; * p < .001. 
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Table 3. Tests of Mediation Summary 
Expectancy Self-Efficacy 
Partial Mediation 
Self-Efficacy  
Full Mediation 
 
Predicting Cannabis Consumption 
 
Positive X -- 
Negative -- X 
 
Predicting Cannabis Dependence Severity (SDS) 
 
Positive -- X 
Negative X -- 
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Figure Legends 
Figure 1. Partial mediation model of the relationship between cannabis outcome expectancy, 
cannabis refusal self-efficacy, weekly cannabis use and dependence severity. Standardized 
parameter estimates are presented. All estimates are statistically significant at p < .05, except 
where indicated (#).
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